HOME >> BIOLOGY >> NEWS
New hope for self-injury sufferers

Communication training, drug therapy combination greatly reduces or eliminates disorder

NASHVILLE, Tenn. - People who routinely injure themselves may do so in order to stimulate a release of feel-good chemicals in the brain, and most of those sufferers can now be helped with an innovative combination of two therapies, according to Travis Thompson, director of Vanderbilt University's John F. Kennedy Center for Research on Human Development.

Thompson is scheduled to present his findings on self-injury as the keynote speaker at the prestigious British Intellectual and Learning Disabilities (BILD) Conference in London Sept. 14.

Thompson and his colleagues have concluded that many of the estimated 50,000 to 300,000 Americans with developmental disabilities who injure themselves with acts such as head banging and self-biting do so either as a primitive form of communication or to stimulate the release of beta endorphins (the brain's natural "morphine") in the brain. Thompson's latest research indicates that sufferers can be helped dramatically by combining communication training with a regimen of the drug naltrexone, which blocks the brain's opiate receptors.

"This particular combination of therapies works because many people with severe disabilities self-injure either as a means of communicating basic needs or wants or because doing so releases beta endorphin," said Thompson, a professor of psychology, special education and psychiatry at Vanderbilt. "If you can provide an alternative form of communication that they understand, they will do that instead of self-injuring. And by combining two treatments - augmentative communication training and naltrexone - it appears we can greatly reduce or stop self-injury in most cases."

Naltrexone works by blocking the brain's opiate receptors, Thompson explained, so that when beta endorphin is released following self-
'"/>

Contact: Peggy Shaw
peggy.shaw@vanderbilt.edu
615-343-8557
Vanderbilt University
8-Sep-1999


Page: 1 2 3

Related biology news :

1. Sickle cell sufferers living longer, dying less from their disease
2. Physicists use fractals to help Parkinsons sufferers
3. Finding may help eczema sufferers tolerate smallpox vaccine
4. Hebrew University, German and British researchers develop means to help stress sufferers
5. Xyzal shows significant improvements in quality of life for persistent allergic rhinitis sufferers
6. Potential allergy vaccine boosts hope for sufferers
7. Heroin users mystery a hope for back pain sufferers
8. Doctors failure to reevaluate asthma severity hurts wheezing sufferers
9. New hope for neurodegenerative disease sufferers
10. Study points to positive results from vitamin D supplements for MS sufferers
11. Human trials of new vaccine technique prove promising for allergy sufferers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/19/2019)... ... 2019 , ... The Laser Institute (LIA)'s 38th ... held in Orlando, Florida and featured the conference’s many firsts. A meeting of ... with a deeper industry foci, more expansive technical sessions, and a new Business ...
(Date:10/17/2019)... , ... October 15, 2019 , ... ... Media for the Microbiological Community”. , Microbiology International currently manufactures ready-to-use culture broth ... also offers pre-poured agar plates & liquid supplements. , This major step underpins ...
(Date:10/17/2019)... ... October 16, 2019 , ... The International Society for ... Baseline® Guide: Water and Steam Systems (Third Edition) . This guide provides in-depth ... systems. Industry professionals can better understand Good Manufacturing Practices (GMPs), to comply with ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 01, 2019 , ... Today Cereset®, the ... the midway point of its randomized research trial for individuals with persisting symptoms ... the efficacy of a non-invasive technology which compares tones delivered to a subject’s ...
(Date:10/3/2019)... ... October 02, 2019 , ... Rapid Novor, Inc., the ... that it has moved into a new, 5000 sqft, purpose-built, state-of-the-art facility. Now ... demonstrates the company's continuous commitment to quality research and service offerings. ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer ... focused on the development of therapies to treat central nervous system (CNS) ...
(Date:9/17/2019)... ... 17, 2019 , ... Catalent, a global leader in clinical ... Asia Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials ... On Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney will present “Singapore: APAC’s ...
Breaking Biology Technology:
Cached News: